GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABBV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for AbbVie stock after gaining 0.250%
(Updated on Apr 18, 2024)

Hold candidate since Apr 16, 2024 Gain 1.30% PDF

The AbbVie stock price gained 0.250% on the last trading day (Thursday, 18th Apr 2024), rising from $164.25 to $164.66. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.83% from a day low at $164.43 to a day high of $167.44. The price has been going up and down for this period, and there has been a -1.93% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 710 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $706.46 million.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $161.83 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect AbbVie stock with a 90% probability to be traded between $164.80 and $186.21 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABBV Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 1.85%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The AbbVie stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $175.15. On a fall, the stock will find some support from the short-term average at $164.56. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AbbVie stock

AbbVie finds support from accumulated volume at $164.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.01 between high and low, or 1.83%. For the last week, the stock has had daily average volatility of 1.71%.

AbbVie is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: $154.79 (-5.99%) (This stock has medium daily movements and this gives medium risk. Low RSI14 is 19 which reduces the risk some. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (ABBV) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect AbbVie Inc to open at $165.51, and during the day (based on 14 day Average True Range), to move between $161.36 and $167.96, which gives a possible trading interval of +/-$3.30 (+/-2.00%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 4.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $164.40 (0.16%) than the resistance at $167.90 (1.97%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

AbbVie will release earnings BMO on Friday, April 26, 2024.The consensus among the analysts for the expected earnings (EPS) is $2.26. We will update the financials statements for AbbVie, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.42% in the first trading day after earnings release.

Is AbbVie Inc stock A Buy?

AbbVie holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.640 Hold/Accumulate Unchanged

Predicted Opening Price for AbbVie Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$165.51 ( 0.516%) $164.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABBV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 168.52 2.34 %
R2 167.37 1.65 %
R1 166.66 1.21 %
Current price: 164.66
Support S1 164.36 -0.182 %
S2 163.65 -0.613 %
S3 162.50 -1.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 176.27 7.05 %
R2 173.29 5.24 %
R1 167.90 1.97 %
Current price 164.66
Support S1 164.40 -0.158%
S2 164.22 -0.267%
S3 162.28 -1.45%

ABBV Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 12, 2024 Apr 12, 2024 May 15, 2024 $1.55 0.94%
2 Jan 15, 2024 Jan 15, 2024 Feb 15, 2024 $1.55 0.88%
3 Oct 27, 2023 Jan 12, 2024 Feb 15, 2024 $1.55 0.88%
4 Sep 08, 2023 Oct 12, 2023 Nov 15, 2023 $1.48 1.08%
5 Jun 22, 2023 Jul 14, 2023 Aug 15, 2023 $1.48 0.97%

FAQ

What is the symbol for AbbVie Stock and on which exchange is it traded?
The symbol for AbbVie is ABBV and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AbbVie Stock?
AbbVie holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy AbbVie Stock?
AbbVie Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AbbVie Stock.

What's the current price of AbbVie Stock?
As of the end of day on the 2024-04-18, the price of an AbbVie (ABBV) share was $164.66.

What is the 52-week high and low for AbbVie Stock?
The 52-week high for AbbVie Stock is $182.89 and the 52-week low is $130.96.

What is the market capitalization of AbbVie Stock?
As of the 2024-04-18, the market capitalization of AbbVie is 291.555B.

When is the next earnings date for AbbVie?
The upcoming earnings date for AbbVie is Apr 26, 2024.
Click to get the best stock tips daily for free!

About AbbVie Inc

AbbVie AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... ABBV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT